\BOOKMARK [1][-]{section.1}{Abstract}{}% 1
\BOOKMARK [1][-]{section.2}{Introduction}{}% 2
\BOOKMARK [1][-]{section.3}{Methods}{}% 3
\BOOKMARK [2][-]{subsection.3.1}{Study population}{section.3}% 4
\BOOKMARK [1][-]{section.4}{Results}{}% 5
\BOOKMARK [2][-]{subsection.4.1}{Cohort characteristics}{section.4}% 6
\BOOKMARK [2][-]{subsection.4.2}{Host genetic analyses}{section.4}% 7
\BOOKMARK [2][-]{subsection.4.3}{Population structure}{section.4}% 8
\BOOKMARK [2][-]{subsection.4.4}{Genetic invariance of prolonged infection}{section.4}% 9
\BOOKMARK [2][-]{subsection.4.5}{Variants in G glycoprotein significantly associated with prolonged infection}{section.4}% 10
\BOOKMARK [2][-]{subsection.4.6}{Functional interpretation}{section.4}% 11
\BOOKMARK [2][-]{subsection.4.7}{Host response}{section.4}% 12
\BOOKMARK [1][-]{section.5}{Discussion}{}% 13
\BOOKMARK [1][-]{section.6}{Links}{}% 14
\BOOKMARK [2][-]{subsection.6.1}{Software}{section.6}% 15
\BOOKMARK [2][-]{subsection.6.2}{Data sources}{section.6}% 16
\BOOKMARK [1][-]{section.7}{Code availability}{}% 17
\BOOKMARK [1][-]{section.8}{Supplemental methods}{}% 18
\BOOKMARK [2][-]{subsection.8.1}{Study population}{section.8}% 19
\BOOKMARK [2][-]{subsection.8.2}{Biweekly surveillance of RSV infection}{section.8}% 20
\BOOKMARK [2][-]{subsection.8.3}{Descriptive analyses}{section.8}% 21
\BOOKMARK [2][-]{subsection.8.4}{Host DNA collection and genotyping}{section.8}% 22
\BOOKMARK [2][-]{subsection.8.5}{Host genetic analyses of RSV infection in infancy}{section.8}% 23
\BOOKMARK [2][-]{subsection.8.6}{Host genetic analyses for known associations}{section.8}% 24
\BOOKMARK [2][-]{subsection.8.7}{Host acute local immune response}{section.8}% 25
\BOOKMARK [2][-]{subsection.8.8}{RSV whole-genome sequencing}{section.8}% 26
\BOOKMARK [2][-]{subsection.8.9}{Viral sequence alignment}{section.8}% 27
\BOOKMARK [2][-]{subsection.8.10}{Viral population structure}{section.8}% 28
\BOOKMARK [2][-]{subsection.8.11}{Viral variant association testing}{section.8}% 29
\BOOKMARK [2][-]{subsection.8.12}{Public viral sequence data}{section.8}% 30
\BOOKMARK [2][-]{subsection.8.13}{Biological interpretation}{section.8}% 31
\BOOKMARK [1][-]{section.9}{Supplemental figures}{}% 32
